Overview

Description

  • NatureSynthetic
  • Amino Acid Sequence
    • SpeciesHuman
    • SequenceC-DSIGKDGEKQDL
    • Amino acids392 to 403

Specifications

Our Abpromise guarantee covers the use of ab22980 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

General Info

  • Alternative names
    • 2610008O20Rik
    • NALD
    • OTTMUSP00000005454
    • Peroxin 13
    • Peroxin-13
    • Peroxin13
    • Peroxisomal membrane protein PEX 13
    • Peroxisomal membrane protein PEX13
    • Peroxisome biogenesis factor 13
    • PEX 13
    • pex13
    • PEX13_HUMAN
    • RP23-188K3.1
    • ZWS
    see all
  • FunctionComponent of the peroxisomal translocation machinery with PEX14 and PEX17. Functions as a docking factor for the predominantly cytoplasmic PTS1 receptor (PAS10/PEX5). Involved in the import of PTS1 and PTS2 proteins.
  • Involvement in diseaseDefects in PEX13 are the cause of peroxisome biogenesis disorder complementation group 13 (PBD-CG13) [MIM:601789]; also known as PBD-CGH. PBD-CG13 is a peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).
    Defects in PEX13 are a cause of adrenoleukodystrophy neonatal (NALD) [MIM:202370]. NALD is a peroxisome biogenesis disorder (PBD) characterized by the accumulation of very long-chain fatty acids, adrenal insufficiency and mental retardation.
  • Sequence similaritiesBelongs to the peroxin-13 family.
    Contains 1 SH3 domain.
  • Cellular localizationPeroxisome membrane.
  • Information by UniProt

References for Human PEX13 peptide (ab22980)

ab22980 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab22980.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"